RXFP1 Antikörper (AA 735-757)
Kurzübersicht für RXFP1 Antikörper (AA 735-757) (ABIN2873016)
Target
Alle RXFP1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 735-757
-
Aufreinigung
- unpurified serum
-
Immunogen
- 5-10 mg of > 70% pure peptide conjugated to KLH.
-
-
anti-Relaxin/insulin-Like Family Peptide Receptor 1 (RXFP1) (AA 260-409) antibody
RXFP1 Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Relaxin/insulin-Like Family Peptide Receptor 1 (RXFP1) (AA 68-162) antibodyRXFP1 Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 3E3 unconjugated
anti-Relaxin/insulin-Like Family Peptide Receptor 1 (RXFP1) (C-Term) antibodyRXFP1 Reaktivität: Human IHC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Relaxin/insulin-Like Family Peptide Receptor 1 (RXFP1) (AA 685-713), (C-Term) antibodyRXFP1 Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB41815 unconjugated
anti-Relaxin/insulin-Like Family Peptide Receptor 1 (RXFP1) (AA 1-757) antibodyRXFP1 Reaktivität: Human WB Wirt: Maus Polyclonal unconjugated
anti-Relaxin/insulin-Like Family Peptide Receptor 1 (RXFP1) (AA 68-162) antibodyRXFP1 Reaktivität: Human WB, ELISA Wirt: Maus Polyclonal unconjugated
anti-Relaxin/insulin-Like Family Peptide Receptor 1 (RXFP1) (AA 17-151) antibodyRXFP1 Reaktivität: Human ELISA, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Relaxin/insulin-Like Family Peptide Receptor 1 (RXFP1) (AA 110-259) antibodyRXFP1 Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store antibodies at 2-4°C before and at -20°C after rehydration. The product is stable for approximately 3-6 weeks after rehydration at -20°C or below.
-
-
- RXFP1 (Relaxin/insulin-Like Family Peptide Receptor 1 (RXFP1))
-
Andere Bezeichnung
- LGR7 / Relaxin Receptor 1
-
Pathways
- Myometrial Relaxation and Contraction
Target
-
